Identifying the Shedding Patterns of Wildlife Escherichia coli O157:H7 in Experimentally Inoculated Neonatal Jersey Calves
- 1. Department of Population Health and Reproduction, University of California, USA
- 2. Western Institute for Food Safety and Security, University of California, USA
- 3. College of Agriculture and Natural Resources, University of Wyoming, University, USA
- 4. Western Center for Food Safety, University of California, USA
ABSTRACT
Cattle are considered to be a major reservoir host of Shiga-toxin producing enterohemorrhagic Escherichia coli O157:H7. Contaminated foods of bovine origin that have been exposed to bovine or wildlife E. coli O157:H7 isolates are important vehicles of human infections, which can lead to the deadly hemolytic uremic syndrome (HUS). The objective of this study was to determine possible dose-dependent pathogen shedding patterns of a wildlife E. coli O157:H7 strain in neonatal calves. We inoculated six calves, 1-2 day old calves, with either 108 or 109 CFU and collected fecal samples for 11 days post-inoculation to determine the shedding patterns of the inoculated E. coli O157:H7. Calves were then euthanized, with tissues collected for culture. One calf inoculated at 108 CFU and both calves inoculated at 109 CFU became infected. The calf inoculated at 109 CFU, which shed the E. coli O157:H7 isolate for the entire 11 days post-inoculation, had a wider distribution of colonized tissues compared to the other 109 CFU and 108 CFU inoculated calves. We conclude that the wildlife strain has a dose-dependent shedding pattern with a calculated infectious dose (ID50) of 108 CFU.
CITATION
Li X, Antaki Zukoski EM, Nguyen THB, Hoar BR, Jay Russell MT, et al. (2020) Identifying the Shedding Patterns of Wildlife Escherichia coli O157:H7 in Experimentally Inoculated Neonatal Jersey Calves. J Vet Med Res 7(2): 1183.
KEYWORDS
• Escherichia coli O157:H7
• Wildlife
• Calves
• Neonatal
• Dose-dependent
ABBREVIATIONS
EHEC: Enterohaemorrhagic Escherichia coli; E. coli O157:H7: Escherichia coli O157:H7; Stxs: Shiga toxins; HUS: Hemolytic Uremic Syndrome; A/E: Attaching/Effacing; ID50: 50% Infectious Dose; BHI: Brain Heat Infusion; PBS: Phosphate Buffered Saline; LB: Luria Base; eaeA: Intimin; HlyA: Hemolysin A; IACUC: Institutional Animal Care and Use Committee; TRACS: Teaching and Research Animal Care Services; RAMS: Rectoanal Mucosal Swabs; TSB: Tryptic Soy Broth; IMS: Immunomagnetic Separation; PFGE: Pulsed Field Gel Electrophoresis
INTRODUCTION
Escherichia coli are a Gram-negative, rod-shaped bacterium of the Enterobacteriaceae family. Most E. coli strains colonize the gastrointestinal tract of humans and mammals as part of the normal flora. However, some can evolve into pathogenic strains by acquiring virulence factors through plasmids, transposons, bacteriophages, and/or pathogenicity islands. These pathogenic E. coli are characterized by serogroups, pathogenicity mechanisms, clinical symptoms, or virulence factors [1,2]. One major pathogenic group of E. coli strains are the enterohaemorrhagic Escherichia coli (EHEC), which can produce Shiga toxins (Stxs) and cause non-specific diarrhea, hemorrhagic colitis, and potentially life-threatening hemolytic uremic syndrome (HUS) in humans. The occurrence of massive outbreaks of Shiga toxin-producing E. coli infections, especially resulting from the serotype O157:H7 and the risk of developing HUS (the primary cause of acute kidney failure in children in many developed countries) make this pathogen a public health problem of serious concern [3]. Sources of human infection include contaminated foods, primarily ground beef, raw milk, lettuce, spinach, and fresh fruits, as well as waterborne transmission in rural areas through contact with feces from infected animals [4,5].
The natural reservoir of E. coli O157:H7 is in the intestinal tracts of animals, particularly cattle and small domesticated ruminants, like sheep and possibly goats. It can also be carried by pigs, poultry, other domestic farm animals, birds, insects, and wildlife, such as rodents and white-tailed deer. Prevalence within wildlife carriers can be low, but can provide a resource for transmission within local areas and distant geographic locations [6-8]. Ferens and Hovde, 2011, found E. coli O157:H7 in 11.4% of cattle (n=1407), 1.2% of swine (n=1102), 3.6% of sheep and goats (n=364), and in 5.2% of 154 fly pools, where some isolates from cattle, swine, and flies shared indistinguishable subtypes of the bacteria. In another study, 1,071 wild rodents were trapped from October 2009 to August 2011 in the Salinas Valley region to determine the fecal prevalence and risk factors associated with the occurrence of E. coli O157:H7, Salmonella spp., Cryptosporidium spp., and Giardia spp. within agricultural production systems. It was determined that 0.2% of the fecal samples collected from the wild rodents were positive for E. coli O157:H7 [9].
There has been extensive work using animal models to better understand the dynamic pathogenic mechanisms of EHEC, especially with regards to serotype O157:H7. It has been shown that neonatal animals, especially calves, are the susceptible age class for these types of diseases and symptoms, which include diarrhea, hyperemia, fibrinous exudates, enteritis, and the formation of attaching/effacing (A/E) lesions within the intestinal tissues. In contrast, older ruminants have transient watery diarrhea, but are not seriously affected by an E. coli O157:H7 infection. It is thought that E. coli O157:H7 primarily colonizes the rectoanal junction in cattle, which is then responsible for the persistent shedding pattern. The capacity for persistence with episodic shedding has been seen in studies, but there also can be a significant detection problem since the infected animals can be asymptomatic [10-13].
To reduce the risk of E. coli O157:H7 transmission from animals to humans, it’s necessary to determine if the bacterium’s pathogenesis differs among various wildlife strains. Here, we examined the shedding patterns among neonatal Jersey calves inoculated with a wildlife E. coli O157:H7 strain isolated from an agricultural production system. Our objective was to determine dose-dependent characteristics in the host clinical response correlated with isolation in daily fecal excretion and tissue-based cultures.
MATERIALS AND METHODS
Standard growth curve of bacterial strain
The wildlife Escherichia coli O157:H7 strain was isolated from a deer mouse (Peromyscus maniculatus) November 2009 in Monterey County, CA on a spinach produce ranch. Three growth curves were made by incubating a bead of stock inoculum, taken from -80°C frozen banks (Pro-lab, Richmond Hill, Ohio, USA), in 150mL of brain heart infusion, BHI (Sigma-Aldrich, St. Louis, Missouri, USA) broth. Each broth was incubated, plated, and original concentrations were calculated as previously described by Antaki-Zukoski et al., 2018 [14]. The E. coli O157:H7 strain was also evaluated for both Shiga toxins, intimin (eaeA), and hemolysin A (HlyA) virulence genes using an endpoint analysis (Eppendorf, Hauppauge, New York, USA) according to the PCR protocol [3] (data not shown).
Ethics statement
All animal experiments were conducted under the approval by the Institutional Animal Care and Use Committee (IACUC) at the University of California Davis Animal Care and Use program (AUP #15459). Experimental procedures followed the federal guidelines outlined in the “Animal Welfare Act” and “Health Research Extension Act”, where personal protective equipment, standard operating protocols, daily cleaning/observation/animal enrichment, and sedation/euthanasia/necropsy methods were described in detail for the review and approval by the committee.
Animal experiments
Six male calves 1-2-days-old that had received colostrum were purchased from an approved dairy. Each calf was housed individually in the biosafety level-II animal facility at the Teaching and Research Animal Care Services (TRACS). The calves were fed commercial milk replacer without antibiotics twice a day and given free access to water. Bedding material was removed while pens were bleached and rinsed daily, to ensure fresh fecal collection. Upon arrival, each calf was deemed healthy by clinical examination and hematological analysis with a serum chemistry panel and complete blood count. Additionally, each calf was tested for the presence of Cryptosporidium spp. with an acid-fast stain performed on feces. In order to confirm that calves were not colonized with E .coli O157:H7, fresh rectal fecal samples and rectoanal mucosal swabs (RAMS) were collected for three consecutive days prior to inoculation with the wildlife E. coli O157:H7 [15]. Ten grams of each fecal sample was measured into 90mL of Tryptic Soy Broth (TSB) (Sigma-Aldrich, St. Louis, Missouri, USA), while the RAMS were placed in 50mL of TSB. The samples were incubated at 25°C for 2 hours, 42°C for 8 hours followed by immunomagnetic separation (IMS) using anti-O157 antibodies (Dynal Inc, Camarillo, California, USA) and cultured on MacConkey agar with sorbitol, cefixime, and potassium tellurite (Becton, Dickinson, Co, Sparks, Maryland, USA), and Rainbow agar (Biolog, Hayward, California, USA) for the presence of E. coli O157:H7 [14]. If any colonies were considered E. coli O157 suspects, traditional PCR was performed using a set of specific primers to detect O-antigen-encoding rfb regions of E. coli O157:H7 [3]. Once the calves were confirmed negative for Cryptosporidium spp. and E. coli O157H7 prior infections, they were placed in individual pens, separated by one pen length. They were then assigned an E. coli O157:H7 inoculum dose.
Inoculation of animals
One micro bank bead for the wildlife strain, stored at -80°C, was placed in a 250mL flask containing 150mL of BHI. The flasks were incubated at 37°C for 6 hours, while shaking at 100 rpm. Once the determined optical density was reached, the flasks were placed on ice for 15 minutes. At this point the optical density was measured again and the concentration of the stock solution was calculated by using the growth curve from the E. coli O157:H7 strain. From the known stock solution concentration, the inoculums were prepared for the wildlife E. coli O157:H7 strain in 200mL of PBS.
In previous lab studies inoculating neonatal calves with wildlife E. coli O157:H7 strain isolated from a feral swine, at 104 CFU and 107 CFU showed that these inoculum doses were not high enough to cause an infection (data below). To ensure the feral swine and deer mouse strains were distinct from one another and from other E. coli O157:H7 isolates collected in California, a Pulsed Field Gel Electrophoresis (PFGE) was performed. The isolates were digested using the Center for Disease Control and Prevention PulseNet PFGE with XbaI restriction enzyme [16]. A dendogram was constructed by analyzing each digest profile with band matching and phylogenetic clustering analysis methods in Gel ComparII (Applied Maths, Sint-Martens-Laterm, Belgium) computer software. For this study, assuming that the two wildlife E. coli O157:H7 strains have similar pathogenicity patterns once inoculated into a host, one calf served as a negative control, two calves were inoculated with 108 CFU (calf A and calf B), two calves were inoculated with 109 CFU (calf A and calf B), and one calf was inoculated with 1010 CFU (positive control) of the deer mouse wildlife E. coli O157:H7 strain. Serial dilutions from 10-1 to 10-10 were made in 9mL of PBS and plated in triplicate on LB for each stock solution and inoculum. After an overnight incubation at 37° C, the true concentration of each inoculum was calculated. The individually housed calves were intragastrically inoculated with their assigned inoculum dose in 200 ml PBS with a calf gastric feeder (VetOne, Boise, Idaho, USA) followed with another 200mL of PBS as a wash.
Daily sampling and fecal scoring
Fecal samples and RAMS were collected twice daily for the first two days post-inoculation (p.i.) and then collected once a day until the 11th day p.i. Fecal consistency was scored on a scale from 1-4, with 1=Normal, 2=Paste, 3=Liquid, and 4=Water (Table 1). All of the samples were collected in the afternoon and transported back to the laboratory in a refrigerated state. The samples were processed within 24 hours of sampling.
Analytical assays for detecting E. coli O157:H7
Each 10g fecal sample and RAMS were placed in separate whirl packs (eNasco, Fort Atkinson, Wisconsin, USA) containing either 90mL TSB for fecals and 50mL TSB for RAMS, and then incubated for 2 hours at 25°C, 8 hours at 42°C, and held overnight at 6°C. E. coli O157:H7 was recovered using IMS and the Dynal Bead Retriever, with 50 μL of washed beads streaked for isolation on Rainbow agar and another 50 μL streaked for isolation on Sorbitol MacConkey Agar [14]. As performed in our laboratory, this IMS method has been shown to be able to detect as few as 1CFU/10g of calf feces (Data not shown). Two suspect colonies per positive plate were confirmed as E. coli O157:H7using PCR as described above [17]. Confirmed colonies were stored at -80°C in Microbank vials for further analysis.
Euthanasia and necropsy
All calves were euthanized with pentobarbital sodium (Euthasol solution, Virbac, Fort Worth, Texas, USA) intravenously and necropsied on the 11th day p.i. Intestinal sections of the duodenum, jejunum, ileum, cecum, spiral colon, distal colon, and rectum were collected for bacterial culture (approximately 5cm in length). Sections of pancreas, liver, mesenteric lymph node, gall bladder, lung and kidney were also taken for culture (approximately 5g). Each segment of intestine was tied with string by both ends so that the contents and the mucosa could be cultured for the presence of E. coli O157:H7. Once transported to the laboratory, one end of the tissue segment was cut and the contents were collected in a whirl pack bag containing 90mL of TSB. The intestinal tissue was then cut longitudinally to expose the mucosa and placed in a separate whirl pack bag with 90mL of TSB. The non-intestinal tissues were each placed in a bag containing 50mL of TSB. All TSB bags were then incubated for 2h at 25°C, 8h at 42°C, and then held overnight at 6°C. E. coli O157:H7 was recovered using the same method as described above.
Data analysis
The ID50 was determined for the wildlife E. coli O157:H7 strain with binary logistic regression using StataIC 12 (StataCorp LP, College Station, Texas, USA) computer software by calculating the number of calves that became infected over the total number of calves used for each inoculum dose. With these percentages, a curve was generated to determine the dose at which 50% of the calves became infected with the inoculated E. coli O157:H7 strain.
MATERIALS AND METHODS
Standard growth curve of bacterial strain
The wildlife Escherichia coli O157:H7 strain was isolated from a deer mouse (Peromyscus maniculatus) November 2009 in Monterey County, CA on a spinach produce ranch. Three growth curves were made by incubating a bead of stock inoculum, taken from -80°C frozen banks (Pro-lab, Richmond Hill, Ohio, USA), in 150mL of brain heart infusion, BHI (Sigma-Aldrich, St. Louis, Missouri, USA) broth. Each broth was incubated, plated, and original concentrations were calculated as previously described by Antaki-Zukoski et al., 2018 [14]. The E. coli O157:H7 strain was also evaluated for both Shiga toxins, intimin (eaeA), and hemolysin A (HlyA) virulence genes using an endpoint analysis (Eppendorf, Hauppauge, New York, USA) according to the PCR protocol [3] (data not shown).
Ethics statement
All animal experiments were conducted under the approval by the Institutional Animal Care and Use Committee (IACUC) at the University of California Davis Animal Care and Use program (AUP #15459). Experimental procedures followed the federal guidelines outlined in the “Animal Welfare Act” and “Health Research Extension Act”, where personal protective equipment, standard operating protocols, daily cleaning/observation/animal enrichment, and sedation/euthanasia/necropsy methods were described in detail for the review and approval by the committee.
Animal experiments
Six male calves 1-2-days-old that had received colostrum were purchased from an approved dairy. Each calf was housed individually in the biosafety level-II animal facility at the Teaching and Research Animal Care Services (TRACS). The calves were fed commercial milk replacer without antibiotics twice a day and given free access to water. Bedding material was removed while pens were bleached and rinsed daily, to ensure fresh fecal collection. Upon arrival, each calf was deemed healthy by clinical examination and hematological analysis with a serum chemistry panel and complete blood count. Additionally, each calf was tested for the presence of Cryptosporidium spp. with an acid-fast stain performed on feces. In order to confirm that calves were not colonized with E .coli O157:H7, fresh rectal fecal samples and rectoanal mucosal swabs (RAMS) were collected for three consecutive days prior to inoculation with the wildlife E. coli O157:H7 [15]. Ten grams of each fecal sample was measured into 90mL of Tryptic Soy Broth (TSB) (Sigma-Aldrich, St. Louis, Missouri, USA), while the RAMS were placed in 50mL of TSB. The samples were incubated at 25°C for 2 hours, 42°C for 8 hours followed by immunomagnetic separation (IMS) using anti-O157 antibodies (Dynal Inc, Camarillo, California, USA) and cultured on MacConkey agar with sorbitol, cefixime, and potassium tellurite (Becton, Dickinson, Co, Sparks, Maryland, USA), and Rainbow agar (Biolog, Hayward, California, USA) for the presence of E. coli O157:H7 [14]. If any colonies were considered E. coli O157 suspects, traditional PCR was performed using a set of specific primers to detect O-antigen-encoding rfb regions of E. coli O157:H7 [3]. Once the calves were confirmed negative for Cryptosporidium spp. and E. coli O157H7 prior infections, they were placed in individual pens, separated by one pen length. They were then assigned an E. coli O157:H7 inoculum dose.
Inoculation of animals
One micro bank bead for the wildlife strain, stored at -80°C, was placed in a 250mL flask containing 150mL of BHI. The flasks were incubated at 37°C for 6 hours, while shaking at 100 rpm. Once the determined optical density was reached, the flasks were placed on ice for 15 minutes. At this point the optical density was measured again and the concentration of the stock solution was calculated by using the growth curve from the E. coli O157:H7 strain. From the known stock solution concentration, the inoculums were prepared for the wildlife E. coli O157:H7 strain in 200mL of PBS.
In previous lab studies inoculating neonatal calves with wildlife E. coli O157:H7 strain isolated from a feral swine, at 104 CFU and 107 CFU showed that these inoculum doses were not high enough to cause an infection (data below). To ensure the feral swine and deer mouse strains were distinct from one another and from other E. coli O157:H7 isolates collected in California, a Pulsed Field Gel Electrophoresis (PFGE) was performed. The isolates were digested using the Center for Disease Control and Prevention PulseNet PFGE with XbaI restriction enzyme [16]. A dendogram was constructed by analyzing each digest profile with band matching and phylogenetic clustering analysis methods in Gel ComparII (Applied Maths, Sint-Martens-Laterm, Belgium) computer software. For this study, assuming that the two wildlife E. coli O157:H7 strains have similar pathogenicity patterns once inoculated into a host, one calf served as a negative control, two calves were inoculated with 108 CFU (calf A and calf B), two calves were inoculated with 109 CFU (calf A and calf B), and one calf was inoculated with 1010 CFU (positive control) of the deer mouse wildlife E. coli O157:H7 strain. Serial dilutions from 10-1 to 10-10 were made in 9mL of PBS and plated in triplicate on LB for each stock solution and inoculum. After an overnight incubation at 37° C, the true concentration of each inoculum was calculated. The individually housed calves were intragastrically inoculated with their assigned inoculum dose in 200 ml PBS with a calf gastric feeder (VetOne, Boise, Idaho, USA) followed with another 200mL of PBS as a wash.
Daily sampling and fecal scoring
Fecal samples and RAMS were collected twice daily for the first two days post-inoculation (p.i.) and then collected once a day until the 11th day p.i. Fecal consistency was scored on a scale from 1-4, with 1=Normal, 2=Paste, 3=Liquid, and 4=Water (Table 1). All of the samples were collected in the afternoon and transported back to the laboratory in a refrigerated state. The samples were processed within 24 hours of sampling.
Analytical assays for detecting E. coli O157:H7
Each 10g fecal sample and RAMS were placed in separate whirl packs (eNasco, Fort Atkinson, Wisconsin, USA) containing either 90mL TSB for fecals and 50mL TSB for RAMS, and then incubated for 2 hours at 25°C, 8 hours at 42°C, and held overnight at 6°C. E. coli O157:H7 was recovered using IMS and the Dynal Bead Retriever, with 50 μL of washed beads streaked for isolation on Rainbow agar and another 50 μL streaked for isolation on Sorbitol MacConkey Agar [14]. As performed in our laboratory, this IMS method has been shown to be able to detect as few as 1CFU/10g of calf feces (Data not shown). Two suspect colonies per positive plate were confirmed as E. coli O157:H7using PCR as described above [17]. Confirmed colonies were stored at -80°C in Microbank vials for further analysis.
Euthanasia and necropsy
All calves were euthanized with pentobarbital sodium (Euthasol solution, Virbac, Fort Worth, Texas, USA) intravenously and necropsied on the 11th day p.i. Intestinal sections of the duodenum, jejunum, ileum, cecum, spiral colon, distal colon, and rectum were collected for bacterial culture (approximately 5cm in length). Sections of pancreas, liver, mesenteric lymph node, gall bladder, lung and kidney were also taken for culture (approximately 5g). Each segment of intestine was tied with string by both ends so that the contents and the mucosa could be cultured for the presence of E. coli O157:H7. Once transported to the laboratory, one end of the tissue segment was cut and the contents were collected in a whirl pack bag containing 90mL of TSB. The intestinal tissue was then cut longitudinally to expose the mucosa and placed in a separate whirl pack bag with 90mL of TSB. The non-intestinal tissues were each placed in a bag containing 50mL of TSB. All TSB bags were then incubated for 2h at 25°C, 8h at 42°C, and then held overnight at 6°C. E. coli O157:H7 was recovered using the same method as described above.
Data analysis
The ID50 was determined for the wildlife E. coli O157:H7 strain with binary logistic regression using StataIC 12 (StataCorp LP, College Station, Texas, USA) computer software by calculating the number of calves that became infected over the total number of calves used for each inoculum dose. With these percentages, a curve was generated to determine the dose at which 50% of the calves became infected with the inoculated E. coli O157:H7 strain.
Table 1: Explanation of daily fecal scoring for each of the six experimental calves.
| Score | Status | Description |
| 1 | Normal | Forms a pile on bedding |
| 2 | Paste | Pile has a flatter surface area |
| 3 | Liquid | Fecal pile runs through bedding |
| 4 | Water | Fecal contains flecks of tissue and material |
RESULTS AND DISCUSSION
Our definition of an infected calf was one that shed the wildlife E. coli O157:H7 inoculum for more than 48 hours p.i. and was culture positive in at least one of its tissues at necropsy on day 11 p.i. This was to account for passage of the inoculum through the gastrointestinal tract without attaching/colonizing the actual tissues. The wildlife E. coli O157:H7 strain used for this study was PCR-confirmed positive for both Shiga toxins, the attaching/effacing (eaeA), and the hemolysin A (HlyA) genes. By PFGE analysis, the deer mouse E. coli O157:H7 strain was different from the feral swine strain as well as three other E. coli O157:H7 strains collected from bovine feces in various parts of California (Figure 1).
Figure 1 PFGE dendogram of both wildlife and bovine Escherichia coli O157:H7 isolated from various parts of California, USA. Bovine strain 8055 isolated from Yolo County, Deer mouse inoculum strain isolated from Monterey County, Bovine strain 14A isolated from Imperial County, Bovine strain W1 isolated from Colusa County, and Feral pig strain 1174 isolated from San Benito County.
Higher average fecal scores were observed in the 109 CFU inoculum group compared to the calves inoculated with 108 CFU. The positive control calf stayed consistent at a score of 1, while the negative control calf fluctuated between a score of 1-3 (Figure 2). IMS and culture was performed on daily fecal and RAMS collections for the detection of the inoculated E. coli O157:H7 strain. Calf B from the low inoculum dose shed for six days, while Calf A stopped shedding after four days post-inoculation. Both calves inoculated at 109 CFU shed longer than the lower dose inoculum group, with Calf B shedding for 7 days and the Calf A shedding for the entire duration of the trial. The positive control also shed the entire experimental time of eleven days. The E. coli O157:H7 inoculum was never recovered from the negative control. Table 2 represents the IMS daily collection results.
Figure 2 Average daily fecal scores for each inoculum group of experimental calves. Negative control: negative control calf; Lower inoculum group: average fecal scores from the calves inoculated with 108 CFU of the wildlife Escherichia coli O157:H7; Higher inoculum group: average fecal scores from the calves inoculated with 109 CFU of the wildlife Escherichia coli O157:H7; Positive control: positive control calf inoculated with 1010 CFU of the wildlife Escherichia coli O157:H7.
Since the negative control calf received fecal scores between1-3, it was determined that there could be another pathogen causing these clinical signs. A possible conclusion was that the calf contracted Cryptosporidium spp. before the experiment and was pre-screened negative, but the infection caused clinical signs while in the experiment. It has been reported that neonatal calves infected with the protozoan Cryptosporidium spp. are usually asymptomatic, and mainly stressed animals show clinical manifestations of the disease associated with various degrees of diarrhea [18]. The negative control calf might have been exposed to the Cryptosporidim spp. protozoa prior to or during transportation, and then stressed due to the experiment, causing clinical signs of diarrhea. This is in comparison to the positive control that had normal feces throughout the entire experiment. Consequently, clinical signs of diarrhea and fecal score differences between inoculum doses could not be correlated to the E. coli O157:H7 inoculum.
Due to animal welfare, a low dose inoculum experiment was not performed with this wildlife E. coli O157:H7 strain, but an E. coli O157:H7 strain isolated from feral swine was experimentally inoculated in neonatal calves in previous studies using doses of 104 CFU and 107 CFU (Table 2). Since no animals were considered to be infected with the feral swine strain, higher inoculum doses were used instead for the current study. This is a limitation, but assuming the two strains behave the same in neonatal calves, the infectious dose at 50% was calculated to show that 108 CFU is the ID50 value for the deer mouse wildlife E. coli O157:H7 strain.
On the 11th day post-inoculation, the calves were euthanized and necropsied. IMS and culture was performed on all tissues and intestinal contents that were collected from each calf. The wildlife E. coli O157:H7 inoculum was never recovered from the pancreas, liver, mesenteric lymph node, gall bladder, lung, or kidney from any of the calves. Recovery of E. coli O157:H7 wildlife strain from tissues is shown in Table 3. The E. coli O157:H7 inoculum was recovered from at least one intestinal tissue in all calves except for the negative control and Calf A inoculated at 10?8 CFU. Due to its negative fecal and RAMS cultures after four days post-inoculation and tissue culture at necropsy, by our case definition Calf A at 108 CFU was considered not infected.
The infectious ID50 for the wildlife E. coli O157:H7 strain was calculated to be 108 CFU. One of two calves inoculated at 108 CFU was considered infected. Both calves inoculated at 109 CFU were deemed infected due to their long shedding period of E. coli O157:H7 [2,19]. Although our case numbers are limited, there was also a dose-dependent trend seen in the cultured tissues that were taken from each calf. It appeared that if a calf was inoculated with the higher dose of the wildlife E. coli O157:H7, it would shed for a longer period of time and have culture-positive tissues when tested at the end of the experiment.
Table 2: Daily collection IMS results for shedding of the wildlife Escherichia coli O157:H7 in each calf following oral inoculation.
| Wildlife E. coli O157:H7 isolated from a Feral Swine | Wildlife E. coli O157:H7 isolated from a Deer Mouse | |||||||||||
| Days p.i. | Negative | Calf A 10?CFU | Calf B 10?CFU | Calf C 10?CFU | Calf D 10?CFU | Calf A 10?CFU | Negative | Calf A 10?CFU | Calf B 10?CFU | Calf A 10?CFU | Calf B 10?CFU | Positive (10¹?CFU) |
| 1 | - | - | - | - | - | - | - | + | + | + | + | + |
| 2 | - | - | - | - | - | - | - | + | + | + | + | + |
| 3 | - | - | - | - | - | - | - | + | + | + | + | + |
| 4 | - | - | - | - | - | - | - | + | - | + | + | |
| 5 | - | - | - | - | - | - | - | - | - | + | + | + |
| 6 | - | - | - | - | - | - | - | - | + | + | + | + |
| 7 | - | - | - | - | - | - | - | - | - | + | + | + |
| 8 | - | - | - | - | - | - | - | - | - | + | - | + |
| 9 | - | - | - | - | - | - | - | - | - | + | - | + |
| 10 | - | - | - | - | - | - | - | - | - | + | - | + |
| 11 | N/A | N/A | N/A | N/A | N/A | N/A | - | - | + | - | + | |
| (+) indicates presence of the Escherichia coli O157:H7 inoculum tested by Immunomagnitic Separation and PCR-confirmed on the day of collection from each calf, (-) indicates the Escherichia coli O157:H7 inoculum was not detected on the day of collection by Immunomagnetic Separation from each calf; (N/A) calves were euthanized the day prior. | ||||||||||||
Table 3: IMS detection of the wildlife Escherichia coli O157:H7 in intestinal tissue 11 days post-inoculation.
| Tissue Segment | Negative | Calf A 10?CFU | Calf B 10?CFU | Calf A 10?CFU | Calf B 10?CFU | Positive (10¹?CFU) |
| Duodenum | - | - | - | + | - | + |
| Jejunum | - | - | - | + | - | + |
| Ileum | - | - | - | + | + | + |
| Cecum | - | - | - | + | + | + |
| Spiral Colon | - | - | + | - | - | + |
| Distal Colon | - | - | - | + | - | + |
| Rectum | - | - | - | - | - | + |
| (+) indicates that the wildlife Escherichia coli O157:H7 w +as detected in the tissue with Immunomagnetic Separation and PCR-confirmed, (-) indicates the wildlife Escherichia coli O157:H7 was not detected in the tissue | ||||||
CONCLUSION
Wild animals can potentially carry E. coli O157:H7, causing transmission to humans when they are in contact with farm animals or produce fields [20]. Only a limited number of experimental studies have evaluated the ability of wildlife species carrying and transmitting the E. coli O157:H7 pathogen through the environment or to other animals. Due to this limitation, we don’t fully understand the potential virulence of these wildlife isolates. We have shown in this study that a wildlife E. coli O157:H7 isolate, from a deer mouse, has the capability to experimentally infect neonatal calves at a high inoculum dose of 108 CFU, with a wide range of intestinal tissue colonization if infection continues for a week or longer. Future studies could further examine the host-pathogen interaction between these wildlife isolates and their reservoirs by determining the infectious dose/clinical signs in deer mouse models.
ACKNOWLEDGEMENT
The authors are grateful to the Teaching and Research Animal Care services for their assistance on the purchasing, care, and transportation of the animals used for this experiment. The authors would also like to thank the California Animal Health and Food Safety, University of California, Davis, for their necropsy floor and their overall assistance. Support for this research was provided to the Western Center for Food Safety contract U01-003-572 from the U.S. Food and Drug Administration. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the U.S. Food and Drug Administration.

